Insights | Gestalt Law

Insights

Ag-Bio Patents and the “Support” Requirement: Lessons from CSIRO v Urrbrae Foods

Federal Court Considers Offshore Performance of Patented Method Claims in Scidera v MLA

Major Shift in Australian PTE Law | Formulation Claims No Longer Eligible for Patent Term Extensions

Preliminary Discovery: An Early Tool for Assessing Generic Entry in Australia

INN-sight: Generic pharmaceutical names and trade mark examination

Applying for a Patent Term Extension in Australia: A Practical Guide

Pharmaceutical Patent Term Extensions in Australia | Understanding the Legal Regime

Computer Implemented Inventions Get a New Lease on Life from the Full Federal Court of Australia

Full Federal Court Upholds Decision to Revoke Patent Term Extension - Novartis AG v Pharmacor Pty Limited [2025] FCAFC 33

Purpose over Form | Federal Court clarifies that Non-Ready to Use Pharmaceuticals and Process or Result Limited Products can be Eligible for Patent Term Extensions

Formulations confirmed as eligible for Patent Term Extensions in Australia | Cipla Australia Pty Ltd v Novo Nordisk A/S [2024] FCA 1414